ArticleVaccines2022

Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study.

Warawut Chaiwong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.